Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Total 13F shares
-
18,365,550
-
Share change
-
+834,954
-
Total reported value
-
$149,202,914
-
Put/Call ratio
-
219%
-
Price per share
-
$8.12
-
Number of holders
-
93
-
Value change
-
+$6,984,615
-
Number of buys
-
39
-
Number of sells
-
41
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q3 2021
As of 30 Sep 2021,
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,365,550 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Skylands Capital, LLC, AVENIR CORP, Neuberger Berman Group LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Redmile Group, LLC, Sargent Investment Group, LLC, Soleus Capital Management, L.P., and STATE STREET CORP.
This page lists
93
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.